Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2048 clinical trials
Safety Study of AB0024 in Patients With Advanced Solid Tumors

This is a first-in-human, open-label, sequential dose escalation study to evaluate AB0024 in patients with advanced solid tumors.

  • 20 views
  • 08 Nov, 2020
  • 2 locations
A Study of SKB315 in Patients With Advanced Solid Tumors

injection in patients with advanced solid tumors.

  • 0 views
  • 26 May, 2022
  • 1 location
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

To evaluate the safety and tolerability of SPH5030 tablets in subjects with HER2-positive advanced solid tumors

  • 0 views
  • 15 Mar, 2022
  • 1 location
Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

The primary purpose of this study is to assess the safety and tolerability of RP-6306 in combination gemcitabine, in patients with eligible advanced solid tumors, determine the maximum tolerated

  • 0 views
  • 28 May, 2022
  • 4 locations
Study on TIL for the Treatment of Advanced Solid Tumors

This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with Advanced malignant solid tumors.Autologous TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lymphodepletion treatment with fludarabine and cyclophosphamide.

  • 0 views
  • 04 Oct, 2022
  • 1 location
First in Human Study of M1069 in Advanced Solid Tumors

The main purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and early signs of efficacy of M1069 in participants with advanced solid malignancies.

  • 12 views
  • 07 Oct, 2022
  • 3 locations
  • 0 views
  • 24 Apr, 2022
  • 1 location
A Study of EMB-02 in Participants With Advanced Solid Tumors

The primary purpose of this study is to identify the recommended Phase 2 dose(s) (RP2Ds) and schedule assessed to be safe for EMB-02 and to characterize the safety and tolerability of EMB-02 at the RP2Ds. Pharmacokinetics (PK), immunogenicity, and the anti-tumor activity of EMB-02 will also be assessed.

  • 0 views
  • 24 Apr, 2022
  • 6 locations
Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Prospective, open-label, two-way crossover, phase Ib drug-drug interaction study in patients with advanced solid tumors

  • 0 views
  • 07 Oct, 2021
  • 2 locations
APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

chemotherapeutic agent. A total of 35 patients with advanced solid tumors or lymphomas have been treated with APG-1387 in two Phase I dose-escalation studies in Australia and in China. Ten dose levels have been

  • 11 views
  • 04 Oct, 2022
  • 3 locations